Table 1.
Training cohort | Extra validation cohort | ||||||
---|---|---|---|---|---|---|---|
Characteristics | Number of cases | % (percentage) | Characteristics | Number of cases | % (percentage) | ||
Age at initial diagnosis (years) | 329 (16–90) | Age at initial diagnosis (years) | 232 (31–89) | ||||
Age | Age | ||||||
>65 | 119 | 36.17 | >65 | 142 | 61.21 | ||
≤65 | 210 | 63.83 | ≤65 | 90 | 38.79 | ||
Gender | Gender | ||||||
Men | 226 | 68.69 | Men | 171 | 73.71 | ||
Women | 103 | 31.31 | Women | 61 | 26.29 | ||
Tumor stage | Tumor stage | ||||||
I | 155 | 47.11 | I | 36 | 15.52 | ||
II | 74 | 22.49 | II | 106 | 45.69 | ||
III | 76 | 23.10 | III | 71 | 30.60 | ||
IV | 3 | 0.91 | IV | 19 | 8.19 | ||
Unknown | 21 | 6.38 | |||||
Grade | Prior malignancy | ||||||
1 | 50 | 15.20 | Yes | 30 | 12.93 | ||
2 | 155 | 47.11 | No | 202 | 87.07 | ||
3 | 107 | 32.52 | |||||
4 | 12 | 3.65 | |||||
Unknown | 5 | 1.52 |